These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27141881)
1. Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery. Kaur H; Desai SD; Kumar V; Rathi P; Singh J Anticancer Agents Med Chem; 2016; 16(11):1355-1377. PubMed ID: 27141881 [TBL] [Abstract][Full Text] [Related]
2. Polymer-Drug Conjugates for Anticancer Drug Delivery. Wadhwa S; Mumper RJ Crit Rev Ther Drug Carrier Syst; 2015; 32(3):215-45. PubMed ID: 26080809 [TBL] [Abstract][Full Text] [Related]
3. Carbon nanotubes for delivery of small molecule drugs. Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402 [TBL] [Abstract][Full Text] [Related]
4. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel. Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304 [TBL] [Abstract][Full Text] [Related]
5. Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study. Eldar-Boock A; Blau R; Ryppa C; Baabur-Cohen H; Many A; Vicent MJ; Kratz F; Sanchis J; Satchi-Fainaro R J Drug Target; 2017; 25(9-10):829-844. PubMed ID: 28737432 [TBL] [Abstract][Full Text] [Related]
6. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630 [TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight polymer-drug conjugates for synergistic anticancer activity of camptothecin and doxorubicin combinations. Camacho KM; Menegatti S; Mitragotri S Nanomedicine (Lond); 2016 May; 11(9):1139-51. PubMed ID: 27079141 [TBL] [Abstract][Full Text] [Related]
9. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512 [TBL] [Abstract][Full Text] [Related]
10. Delivery of HSP90 Inhibitor Using Water Soluble Polymeric Conjugates with High Drug Payload. Suárez Del Pino JA; Kolhatkar R Pharm Res; 2017 Dec; 34(12):2735-2748. PubMed ID: 28913790 [TBL] [Abstract][Full Text] [Related]
11. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation. Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124 [TBL] [Abstract][Full Text] [Related]
12. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. Duncan R; Gac-Breton S; Keane R; Musila R; Sat YN; Satchi R; Searle F J Control Release; 2001 Jul; 74(1-3):135-46. PubMed ID: 11489490 [TBL] [Abstract][Full Text] [Related]
13. Overview. Prudhomme M Anticancer Agents Med Chem; 2017; 17(1):2. PubMed ID: 28143383 [No Abstract] [Full Text] [Related]
14. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers. Sun H; Yarovoy I; Capeling M; Cheng C Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270 [TBL] [Abstract][Full Text] [Related]
15. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482 [TBL] [Abstract][Full Text] [Related]
16. Triple Block Nanocarrier Platform for Synergistic Cancer Therapy of Antagonistic Drugs. Surnar B; Jayakannan M Biomacromolecules; 2016 Dec; 17(12):4075-4085. PubMed ID: 27936725 [TBL] [Abstract][Full Text] [Related]
17. Polymer-protein and polymer-drug conjugates in cancer therapy. Thanou M; Duncan R Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229 [TBL] [Abstract][Full Text] [Related]
19. Engineered Polymer-Transferrin Conjugates as Self-Assembling Targeted Drug Delivery Systems. Makwana H; Mastrotto F; Magnusson JP; Sleep D; Hay J; Nicholls KJ; Allen S; Alexander C Biomacromolecules; 2017 May; 18(5):1532-1543. PubMed ID: 28350442 [TBL] [Abstract][Full Text] [Related]
20. Exploring the role of polymeric conjugates toward anti-cancer drug delivery: Current trends and future projections. Khan J; Alexander A; Ajazuddin ; Saraf S; Saraf S Int J Pharm; 2018 Sep; 548(1):500-514. PubMed ID: 29964172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]